Consistent with our results, other studies to date have shown that patients with MM have higher levels of calretinin than other subjects who were also exposed to asbestos [8,21,30], suggesting calretinin behaves similarly to mesothelin and other biomarkers [30]. This evidence concerns the gene MSLN and Miyoshi myopathy.